Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current and future perspectives of chimeric antigen receptors against glioblastoma. | Immunother Adv | 2022 | 36284838 | PubTator, text mining | PubMed |
| Integrative analysis of macrophage ribo-Seq and RNA-Seq data define glucocorticoid receptor regulated inflammatory response genes into distinct regulatory classes. | Comput Struct Biotechnol J | 2022 | 36284713 | PubTator, text mining | PubMed |
| Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. | Elife | 2022 | 36282174 | PubTator, text mining | PubMed |
| Häufigkeit, Spektrum und Risikofaktoren von Long-COVID. | Pneumo News | 2022 | 36281239 | PubTator, text mining | PubMed |
| Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancer. | Front Oncol | 2022 | 36276080 | PubTator, text mining | PubMed |
| A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer. | Front Cell Dev Biol | 2022 | 36274838 | PubTator, text mining | PubMed |
| Mechanisms of CD40-dependent cDC1 licensing beyond costimulation. | Nat Immunol | 2022 | 36271147 | PubTator, text mining | PubMed |
| The prognostic impact of the immune signature in head and neck squamous cell carcinoma. | Front Immunol | 2022 | 36268020 | PubTator, text mining | PubMed |
| A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma. | Front Genet | 2022 | 36267408 | PubTator, text mining | PubMed |
| Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma. | PLoS One | 2022 | 36264920 | PubTator, text mining | PubMed |
| Engineering neoantigen vaccines to improve cancer personalized immunotherapy. | Int J Biol Sci | 2022 | 36263174 | PubTator, text mining | PubMed |
| Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer. | Dis Markers | 2022 | 36263004 | PubTator, text mining | PubMed |
| Tumor buster - where will the CAR-T cell therapy 'missile' go? | Mol Cancer | 2022 | 36261831 | PubTator, text mining | PubMed |
| GM-CSF-activated human dendritic cells promote type 1 T follicular helper cell polarization in a CD40-dependent manner. | J Cell Sci | 2022 | 36254574 | PubTator, text mining | PubMed |
| CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment. | Technol Cancer Res Treat | 2022 | 36254536 | PubTator, text mining | PubMed |
| Expression Analysis of Ligand-Receptor Pairs Identifies Cell-to-Cell Crosstalk between Macrophages and Tumor Cells in Lung Adenocarcinoma. | J Immunol Res | 2022 | 36249427 | PubTator, text mining | PubMed |
| Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation. | Front Immunol | 2022 | 36248785 | PubTator, text mining | PubMed |
| GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis. | Front Endocrinol (Lausanne) | 2022 | 36246907 | PubTator, text mining | PubMed |
| Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. | Front Genet | 2022 | 36246622 | PubTator, text mining | PubMed |
| Integration of three machine learning algorithms identifies characteristic RNA binding proteins linked with diagnosis, immunity and pyroptosis of IgA nephropathy. | Front Genet | 2022 | 36246620 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=57